Neoplasms, Kidney Completed Phase 3 Trials for Sorafenib (DB00398)

Also known as: Kidney Neoplasms / Kidney Neoplasm

IndicationStatusPhase
DBCOND0032585 (Neoplasms, Kidney)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00678392Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell CancerTreatment